Management of hereditary thyroid cancer in children

Michael A. Skinner

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hereditary thyroid cancer in childhood occurs in the setting of Multiple Endocrine Neoplasia types 2A and 2B, and familial medullary thyroid carcinoma, FMTC. Prophylactic thyroidectomy in childhood has been recommended in patients found to have inherited mutations in the RET protooncogene, to prevent the development of medullary thyroid carcinoma. In this report are presented the clinical and genetic aspects of hereditary thyroid cancer in children, as well as surgical recommendations and medium-term outcome results.

Original languageEnglish (US)
Pages (from-to)101-104
Number of pages4
JournalSurgical Oncology
Volume12
Issue number2
DOIs
StatePublished - Aug 2003

Fingerprint

Thyroid Neoplasms
Multiple Endocrine Neoplasia Type 2b
Multiple Endocrine Neoplasia Type 2a
Thyroidectomy
Mutation
Medullary Thyroid cancer
Familial medullary thyroid carcinoma

Keywords

  • Medullary thyroid carcinoma
  • Multiple endocrine neoplasia
  • RET protooncogene

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Management of hereditary thyroid cancer in children. / Skinner, Michael A.

In: Surgical Oncology, Vol. 12, No. 2, 08.2003, p. 101-104.

Research output: Contribution to journalArticle

Skinner, Michael A. / Management of hereditary thyroid cancer in children. In: Surgical Oncology. 2003 ; Vol. 12, No. 2. pp. 101-104.
@article{73ea45129b4640e9832e8d7fe5ace4c8,
title = "Management of hereditary thyroid cancer in children",
abstract = "Hereditary thyroid cancer in childhood occurs in the setting of Multiple Endocrine Neoplasia types 2A and 2B, and familial medullary thyroid carcinoma, FMTC. Prophylactic thyroidectomy in childhood has been recommended in patients found to have inherited mutations in the RET protooncogene, to prevent the development of medullary thyroid carcinoma. In this report are presented the clinical and genetic aspects of hereditary thyroid cancer in children, as well as surgical recommendations and medium-term outcome results.",
keywords = "Medullary thyroid carcinoma, Multiple endocrine neoplasia, RET protooncogene",
author = "Skinner, {Michael A.}",
year = "2003",
month = "8",
doi = "10.1016/S0960-7404(03)00033-1",
language = "English (US)",
volume = "12",
pages = "101--104",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Management of hereditary thyroid cancer in children

AU - Skinner, Michael A.

PY - 2003/8

Y1 - 2003/8

N2 - Hereditary thyroid cancer in childhood occurs in the setting of Multiple Endocrine Neoplasia types 2A and 2B, and familial medullary thyroid carcinoma, FMTC. Prophylactic thyroidectomy in childhood has been recommended in patients found to have inherited mutations in the RET protooncogene, to prevent the development of medullary thyroid carcinoma. In this report are presented the clinical and genetic aspects of hereditary thyroid cancer in children, as well as surgical recommendations and medium-term outcome results.

AB - Hereditary thyroid cancer in childhood occurs in the setting of Multiple Endocrine Neoplasia types 2A and 2B, and familial medullary thyroid carcinoma, FMTC. Prophylactic thyroidectomy in childhood has been recommended in patients found to have inherited mutations in the RET protooncogene, to prevent the development of medullary thyroid carcinoma. In this report are presented the clinical and genetic aspects of hereditary thyroid cancer in children, as well as surgical recommendations and medium-term outcome results.

KW - Medullary thyroid carcinoma

KW - Multiple endocrine neoplasia

KW - RET protooncogene

UR - http://www.scopus.com/inward/record.url?scp=0142043825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142043825&partnerID=8YFLogxK

U2 - 10.1016/S0960-7404(03)00033-1

DO - 10.1016/S0960-7404(03)00033-1

M3 - Article

C2 - 12946481

AN - SCOPUS:0142043825

VL - 12

SP - 101

EP - 104

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 2

ER -